Literature DB >> 25253391

Effect of myogenic stem cells on the integrity and histomorphology of repaired transected external anal sphincter.

Joseph L Fitzwater1, Kathryn B Grande, Joseph L Sailors, Jesus F Acevedo, R Ann Word, Clifford Y Wai.   

Abstract

INTRODUCTION AND HYPOTHESIS: The objective was to evaluate the effect of myogenic stem cells on histological properties and the volume of striated muscle of the external anal sphincter after transection and repair.
METHODS: Histological analysis was performed on the external anal sphincters of 40 young female rats euthanized at 7 or 90 days after transection and repair and randomization to injection of either phosphate buffered solution (PBS) or myogenic stem cells (SC) at the transection site. Sphincter complexes, previously evaluated for neurophysiological function, were processed for histology and analyzed for possible disruption, amount of inflammation, and volume of striated muscle. The relationship between the muscular disruption and contractile force of sphincters was evaluated.
RESULTS: Disruption was seen in 100 % of sphincters 7 days after repair for both SC and control animals. Eighty-nine percent of controls and 78% of SC-administered animals had intact sphincters at 90 days. Significant inflammatory infiltrate was seen in repaired anal sphincters for both the PBS and the SC groups at 7 days, and persisted at 90 days, with no difference between treatment groups. Striated muscle volume increased from 7 to 90 days for both control and SC-administered animals. Although there was no difference in volume between treatments, there was substantial temporal improvement in contractile force generation of the sphincters receiving SC compared with those receiving PBS.
CONCLUSION: In this animal model, administration of myogenic stem cells to transected/repaired anal sphincters did not alter the amount of inflammation nor the volume of striated muscle, suggesting that stem cells might improve contractile function through other cellular processes.

Entities:  

Mesh:

Year:  2014        PMID: 25253391     DOI: 10.1007/s00192-014-2496-5

Source DB:  PubMed          Journal:  Int Urogynecol J        ISSN: 0937-3462            Impact factor:   2.894


  12 in total

1.  Preliminary results of myoblast injection into the urethra and bladder wall: a possible method for the treatment of stress urinary incontinence and impaired detrusor contractility.

Authors:  M B Chancellor; T Yokoyama; S Tirney; C E Mattes; H Ozawa; N Yoshimura; W C de Groat; J Huard
Journal:  Neurourol Urodyn       Date:  2000       Impact factor: 2.696

Review 2.  ACOG Practice Bulletin. Episiotomy. Clinical Management Guidelines for Obstetrician-Gynecologists. Number 71, April 2006.

Authors: 
Journal:  Obstet Gynecol       Date:  2006-04       Impact factor: 7.661

3.  In vivo recovery of the injured anal sphincter after repair and injection of myogenic stem cells: an experimental model.

Authors:  Felicia L Lane; Stephanie A Jacobs; Jocelyn B Craig; Gabriel Nistor; Danielle Markle; Karen L Noblett; Kathryn Osann; Hans Keirstead
Journal:  Dis Colon Rectum       Date:  2013-11       Impact factor: 4.585

4.  Neurologic recovery and improved detrusor contractility using muscle-derived cells in rat model of unilateral pelvic nerve transection.

Authors:  Dongdeuk Kwon; Brandon Minnery; Yongtae Kim; Jang Hwan Kim; Fernando de Miguel; Naoki Yoshimura; Michael B Chancellor
Journal:  Urology       Date:  2005-06       Impact factor: 2.649

5.  Macrophages enhance muscle satellite cell proliferation and delay their differentiation.

Authors:  F Merly; L Lescaudron; T Rouaud; F Crossin; M F Gardahaut
Journal:  Muscle Nerve       Date:  1999-06       Impact factor: 3.217

6.  Clinical consequences of anal sphincter rupture during vaginal delivery.

Authors:  E K Fornell; G Berg; O Hallböök; L S Matthiesen; R Sjödahl
Journal:  J Am Coll Surg       Date:  1996-12       Impact factor: 6.113

7.  Role of CC chemokines in skeletal muscle functional restoration after injury.

Authors:  Gordon L Warren; Laura O'Farrell; Mukesh Summan; Tracy Hulderman; Dawn Mishra; Michael I Luster; William A Kuziel; Petia P Simeonova
Journal:  Am J Physiol Cell Physiol       Date:  2004-01-14       Impact factor: 4.249

8.  Muscle-derived cell injection to treat anal incontinence due to obstetric trauma: pilot study with 1 year follow-up.

Authors:  A Frudinger; D Kölle; W Schwaiger; J Pfeifer; J Paede; S Halligan
Journal:  Gut       Date:  2010-01       Impact factor: 23.059

9.  Improved sphincter contractility after allogenic muscle-derived progenitor cell injection into the denervated rat urethra.

Authors:  Tracy W Cannon; Ji Youl Lee; George Somogyi; Ryan Pruchnic; Christopher P Smith; Johnny Huard; Michael B Chancellor
Journal:  Urology       Date:  2003-11       Impact factor: 2.649

10.  Anal-sphincter disruption during vaginal delivery.

Authors:  A H Sultan; M A Kamm; C N Hudson; J M Thomas; C I Bartram
Journal:  N Engl J Med       Date:  1993-12-23       Impact factor: 91.245

View more
  11 in total

1.  Myogenic stem cell-laden hydrogel scaffold in wound healing of the disrupted external anal sphincter.

Authors:  T Ignacio Montoya; Jesus F Acevedo; Benjamin Smith; Patrick W Keller; Joseph L Sailors; Liping Tang; R Ann Word; Clifford Y Wai
Journal:  Int Urogynecol J       Date:  2015-02-03       Impact factor: 2.894

Review 2.  Regenerative medicine for anal incontinence: a review of regenerative therapies beyond cells.

Authors:  Andre Plair; Julie Bennington; James Koudy Williams; Candace Parker-Autry; Catherine Ann Matthews; Gopal Badlani
Journal:  Int Urogynecol J       Date:  2020-11-28       Impact factor: 2.894

3.  Stromal cell derived factor 1 plasmid to regenerate the anal sphincters.

Authors:  Li Sun; Alanna Billups; Anna Rietsch; Margot S Damaser; Massarat Zutshi
Journal:  J Tissue Eng Regen Med       Date:  2022-01-29       Impact factor: 4.323

Review 4.  Evidence-Based Update on Treatments of Fecal Incontinence in Women.

Authors:  Isuzu Meyer; Holly E Richter
Journal:  Obstet Gynecol Clin North Am       Date:  2016-03       Impact factor: 2.844

Review 5.  Regenerative medicine provides alternative strategies for the treatment of anal incontinence.

Authors:  Søren Gräs; Cæcilie Krogsgaard Tolstrup; Gunnar Lose
Journal:  Int Urogynecol J       Date:  2016-06-16       Impact factor: 2.894

6.  Local injection of bone marrow progenitor cells for the treatment of anal sphincter injury: in-vitro expanded versus minimally-manipulated cells.

Authors:  Benedetta Mazzanti; Bruno Lorenzi; Annalisa Borghini; Margherita Boieri; Lara Ballerini; Riccardo Saccardi; Elisabetta Weber; Federica Pessina
Journal:  Stem Cell Res Ther       Date:  2016-06-21       Impact factor: 6.832

7.  Comment on "A new method for treating fecal incontinence by implanting stem cells derived from human adipose tissue: preliminary findings of a randomized double-blind clinical trial".

Authors:  Mohammed Mohammed El-Said; Sameh Hany Emile
Journal:  Stem Cell Res Ther       Date:  2018-04-25       Impact factor: 6.832

8.  Outcomes of primary anal sphincter repair after obstetric injury and evaluation of a novel three-choice assessment.

Authors:  K Kuismanen; K Nieminen; K Karjalainen; K Lehto; J Uotila
Journal:  Tech Coloproctol       Date:  2018-03-15       Impact factor: 3.781

9.  Functional Outcome of Human Adipose Stem Cell Injections in Rat Anal Sphincter Acute Injury Model.

Authors:  Kirsi Kuismanen; Miia Juntunen; Nathaniel Narra Girish; Heikki Tuominen; Heini Huhtala; Kari Nieminen; Jari Hyttinen; Susanna Miettinen
Journal:  Stem Cells Transl Med       Date:  2018-01-31       Impact factor: 6.940

Review 10.  Stem cell therapy for faecal incontinence: Current state and future perspectives.

Authors:  Jacobo Trébol; Ana Carabias-Orgaz; Mariano García-Arranz; Damián García-Olmo
Journal:  World J Stem Cells       Date:  2018-07-26       Impact factor: 5.326

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.